Sol-Del Medical

Company Overview

Snapshot

Founded in September 2017, Sol-Del Medical operates with 1–10 employees. The company has secured funding across two rounds from two investors. In July 2022, Sol-Del Medical received funding from OurCrowd.

Business overview

Sol-Del Medical is a health tech and life sciences company focused on developing and producing an innovative medical PVA (Polyvinyl Alcohol) soluble delivery system. The company specializes in creating a medical-grade PVA for generic use, enabling the insertion of FDA-cleared medicines for topical treatments, OTC creams, ointments, or oils. Its core product is an advanced topical dressing made of multi-cell soluble Medical PVA film, designed to provide controlled release of active agents to the skin upon contact with aqueous fluids like perspiration or external water-based fluids. Sol-Del Medical operates within the drug delivery, pharma, and pharmaceutical sectors, targeting B2B markets.

Company Intelligence Q&A

What is Sol-Del Medical's primary focus?

Sol-Del Medical focuses on the development and production of an innovative medical PVA (Polyvinyl Alcohol) soluble delivery system for topical treatments.

When was Sol-Del Medical founded?

Sol-Del Medical was founded in September 2017.

What type of product does Sol-Del Medical offer?

Sol-Del Medical offers an advanced topical dressing made of multi-cell soluble Medical PVA film, designed for controlled release of active agents to the skin.